Moloney Securities Asset Management LLC lessened its holdings in Roche Holding AG (OTCMKTS:RHHBY – Free Report) by 2.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 26,487 shares of the company’s stock after selling 731 shares during the quarter. Moloney Securities Asset Management LLC’s holdings in Roche were worth $933,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Bard Financial Services Inc. boosted its holdings in Roche by 37.7% during the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock worth $3,866,000 after buying an additional 30,350 shares in the last quarter. Diversified Trust Co boosted its stake in shares of Roche by 1.2% during the 4th quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after acquiring an additional 711 shares in the last quarter. Hantz Financial Services Inc. grew its position in shares of Roche by 0.9% during the 4th quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock valued at $1,176,000 after acquiring an additional 305 shares during the period. Brooklyn Investment Group increased its stake in shares of Roche by 36.6% in the 4th quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock valued at $48,000 after purchasing an additional 363 shares in the last quarter. Finally, Canopy Partners LLC raised its holdings in Roche by 4.6% in the 3rd quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock worth $310,000 after purchasing an additional 344 shares during the period.
Wall Street Analysts Forecast Growth
Separately, Sanford C. Bernstein raised Roche to a “strong-buy” rating in a report on Thursday, January 30th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Roche has an average rating of “Hold”.
Roche Stock Up 0.4 %
RHHBY opened at $39.77 on Monday. The firm’s fifty day simple moving average is $36.62 and its two-hundred day simple moving average is $38.31. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86. Roche Holding AG has a 52-week low of $29.20 and a 52-week high of $42.43.
Roche Company Profile
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Recommended Stories
- Five stocks we like better than Roche
- How to Calculate Options Profits
- 3 Volatility ETFs to Help You Profit from Market Chaos
- Using the MarketBeat Dividend Yield Calculator
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- 3 Healthcare Dividend Stocks to Buy
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBY – Free Report).
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.